Medical Marketing International Group - (MMG).

For what it is a worth small mention in this weeks IC states fair value at the moment without news of partnership / results.
IMO it always was going to be a difficult time to meet deadlines around this time of year hence we still await Genvax results. However as we can see new technology which will help treatment of cancer is working for other companies. This may give rise to fears of competition but it should in fact give us more confidence in this new technology and remember MMI have patents on numerous compounds.There is no reason to expect MMI will be any less successful than companies already securing lucrative partnerships who incidentally seem to have a very limited portfolio of new drugs at the moment. In addition cancer seems to be so complex the market so huge it is hard to see how MMI can fail. Try and find another company with so many possible blockbusters 'any one of which if successful could transform the company'

Happy new year.